564TiP A phase Ib dose-escalation study of ZN-c5, an oral selective estrogen receptor degrader (SERD), in combination with abemaciclib in patients with advanced estrogen receptor (ER)+/HER2- breast cancer
Keogh, G.P., Papish, S., Piskorski, W., Ulanska, M., Jackson, B., Suster, M., Ptaszynski, M., Mina, L.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
LBA13 Dostarlimab + chemotherapy (CT) vs pembrolizumab + CT in metastatic non-squamous non-small cell lung cancer (NSCLC): Updated Asian subgroup analyses of the PERLA trial
Lee, D.H., Ahn, J.S., Lin, S-H., Ulanska, M., Lopez, G.A., Chian, C-F., Cho, L., Szijgyarto, Z., Stjepanovic, N., Lim, S.M.
Published in Annals of oncology (01.11.2023)
Published in Annals of oncology (01.11.2023)
Get full text
Journal Article
1654P A phase Ib/II study of the dual MDMX/MDM2 inhibitor, ALRN-6924, for the prevention of chemotherapy-induced myelosuppression
Andric, Z., Ceric, T., Rancic, M., Jakopovic, M., Ponce Aix, S., Ramlau, R., Ulanska, M., Caldwell, C., Ferrari, D., Annis, A., Vukovic, V., Zaric, B.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
Prevention of Chemotherapy-induced Myelosuppression in SCLC patients treated with the Dual MDMX/MDM2 Inhibitor ALRN-6924
Andric, Z., Ceric, T., Stanetic, M., Rancic, M., Jakopovic, M., Aix, S. Ponce, Ramlau, R., Smit, E., Ulanska, M., Caldwell, C., Ferrari, D., Annis, A., Vukovic, V., Zaric, B.
Published in European journal of cancer (1990) (01.10.2020)
Published in European journal of cancer (1990) (01.10.2020)
Get full text
Journal Article
203P Randomized study of single-agent metronomic versus weekly oral vinorelbine (VNR) as first-line chemotherapy in patients with HR+/HER2- advanced breast cancer
Cazzaniga, M.E., Martinez Jañez, N., Kukielka-Budny, B.D., Ulanska, M., Bourgeois, H., Muñoz Mateu, M., Morales Murillo, S., Bayo, J., Cortesi, L., Pinter, T., Palacova, M., Cherciu, N., Petru, E., Ettl, J., De Almeida, C., Raymond, R., Villanova, G.R., Thanh Minh, C. Ta, Rodrigues, A.C.F., Freyer, G.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
Evaluation of clinical significance of TP53, BCL-2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen
KUPRYJACZYK, J, SZYMANSKA, T, EMERICH, J, ULANSKA, M, PLUZANSKA, A, JEDRYKA, M, GOLUDA, M, CHUDECKA-GLAZ, A, RZEPKA-GORSKA, I, KLIMEK, M, URBANSKI, K, BREBOROWICZ, J, MADRY, R, ZIELINSKI, J, MARKOWSKA, J, TIMOREK, A, STELMACHOW, J, KARPINSKA, G, REMBISZEWSKA, A, ZIOŁKOWSKA, I, KRASZEWSKA, E, DEBNIAK, J
Published in British journal of cancer (24.03.2003)
Published in British journal of cancer (24.03.2003)
Get full text
Journal Article
CLINICAL, PATHOLOGICAL AND MOLECULAR ANALYSIS - A RETROSPECTIVE MULTIVARIATE ANALYSIS OF 229 OVARIAN CANCER PATIENTS TREATED WITH PLATINUM-BASED REGIMEN
Kupryjanczyk, J., Szymanska, T., Madry, R., Karpinska, G., Rembiszewska, A., Timorek, A., Ziolkowska, I., Kraszewska, E., Stelmachow, J., Zielinski, J., Debniak, J., Emerich, J., Ulanska, M., Pluzanska, A., Jedryka, M., Goluda, M., Chudecka-Glaz, A., Rzepka-Gorska, I., Klimek, M., Urbanski, A., Markowska, J.
Published in International journal of gynecological cancer (01.03.2003)
Published in International journal of gynecological cancer (01.03.2003)
Get full text
Journal Article
Evaluation of clinical significance of TP53, BCL-2, BAX and MEKI expression in 229 ovarian carcinomas treated with platinum-based regimen
Kupryjanczyk, J, Szymanska, T, Madry, R, Timorek, A, Stelmachow, J, Karpinska, G, Rembiszewska, A, Ziolekowska, I, Kraszewska, E, Debniak, J, Emerich, J, Uleanska, M, Pleuzanska, A, Jedryka, M
Published in British journal of cancer (24.03.2003)
Published in British journal of cancer (24.03.2003)
Get full text
Journal Article
P21WAF1, P27KIP1, TP53 and C-MYC analysis in 204 ovarian carcinomas treated with platinum-based regimens
Plisiecka-Hałasa, J., Karpińska, G., Szymańska, T., Ziółkowska, I., Mądry, R., Timorek, A., Dębniak, J., Ułańska, M., Jędryka, M., Chudecka-Głaz, A., Klimek, M., Rembiszewska, A., Kraszewska, E., Dybowski, B., Markowska, J., Emerich, J., Płużańska, A., Goluda, M., Rzepka-Górska, I., Urbański, K., Zieliński, J., Stelmachów, J., Chrabowska, M., Kupryjańczyk, J.
Published in Annals of oncology (01.07.2003)
Published in Annals of oncology (01.07.2003)
Get full text
Journal Article
Phase II study of vinorelbine (VRL) alternating i.v. and oral in combination with docetaxel (DTX) as 1 st line chemotherapy (CT) of metastatic breast cancer (MBC)
Blasinska Moriawiec, M., Ułańska, M., Zambrano Quispe, O., Koralewski, P., Tekiela, A., Chmielowska, E., Longerey, B., Lafaye de Micheaux, S.
Published in Journal of clinical oncology (01.06.2005)
Published in Journal of clinical oncology (01.06.2005)
Get full text
Journal Article